Corvite FE
- Form
- Tablet
- Product type
- Multivitamin & Mineral (MVM)
- Serving size
- 1 {Tablet(s)}
Ingredients
Supplement Facts
- Serving size
- 1 {Tablet(s)}
| Ingredients | Amount | %DV |
|---|---|---|
| Sumalate | 25 mg | — |
| Ferronyl Carbonyl Iron | 125 mg | — |
| Folate (Folic Acid) | 1 mg | — |
| Vitamin CCalcium Ascorbate | 160 mg | — |
| Calcium Threonate | 5 mg | — |
| Vitamin B6Pyridoxine Hydrochloride | 10 mg | — |
| Vitamin B12Cyanocobalamin | 15 mcg | — |
| Vitamin D3 (Cholecalciferol)Vitamin D3 (Cholecalciferol) | 1,000 IU | — |
| ZincTRAACS Zinc Glycinate Chelate | 25 mg | — |
| MagnesiumDi-Magnesium Malate | 15 mg | — |
Show other ingredientsHide other ingredients19
Ingredients listed outside the Supplement Facts panel. Amounts and %DV are not required there, so they are not recorded.
| Ingredients | Form |
|---|---|
| Black Iron Oxide | — |
| Citric Acid | — |
| Croscarmellose Sodium | — |
| Di Calcium Phosphate | — |
| Ethyl Cellulose | — |
| FD&C Red #40 Lake | — |
| fumed Silica | — |
| Gum Arabic | — |
| Hydroxypropyl Cellulose | — |
| Hypromellose | — |
| Magnesium Stearate | — |
| Microcrystalline Cellulose | — |
| Polyethylene Glycol | — |
| Polysorbate 80 | — |
| PVP K30 | — |
| Talc | — |
| Titanium Dioxide | — |
| Tripotassium Citrate | — |
| Vegetable oil | — |
Source: DSLD (US NIH) label ID 26580Amounts are as stated on the product label. Check the latest label before you buy.
Where to buy
"Search on …" opens a search by product name. Other products may appear, so check the name and size on the store page.
Intended for
- Adults
Label directions and warnings
Quoted from the label as written. Marketing statements, such as claimed benefits, are not shown.
- Directions
- DOSAGE AND ADMINISTRATION Usual adult dose is 1 tablet daily, or as prescribed by a physician.
- Precautions
- WARNINGS Folic acid alone is improper therapy in the treatment of pernicious anemia and other megaloblastic anemias where vitamin B12 is deficient.
- Folic Acid Folic acid in doses above 1.0 mg daily may obscure pernicious anemia in that hematologic remission can occur while neurological manifestations remain progressive. Pernicious anemia should be excluded before using this product since folic acid may mask the symptoms of pernicious anemia.
- ADVERSE REACTIONS Adverse reactions with iron therapy may include constipation, diarrhea, nausea, vomiting, dark stools and abdominal pain. Adverse reactions with iron therapy are usually transient.
- OVERDOSAGE The clinical course of acute iron overdosage can be variable. Initial symptoms may include abdominal pain, nausea, vomiting, diarrhea, tarry stools melena, hematemesis, hypotension, tachycardia, metabolic acidosis, hyperglycemia, dehydration, drowsiness, pallor, cyanossi, lassitude, seizures, shock and coma.
- PRECAUTIONS General Do not exceed recommended dose. The type of anemia and the underlying cause or causes should be determined before starting therapy with CORVITE(R) FE. Since the anemia may be a result of a sytemic disturbance, such as recurrent blood loss, the underlying cause or causes should be corrected, if possible.
- Geriatric Use Clinical studies on this product have not been performed in subjects aged 65 and over to determine whether elderly subjects respond differently from younger subjects. In general, dose selection for an elderly patient should be cautious.
- Precautions: children
- WARNING: Accidental overdose of iron-containing products is a leading cause of fatal poisoning in children under 6. KEEP THIS PRODUCT OUT OF THE REACH OF CHILDREN. In case of accidental overdose, call a doctor or poison control center immediately.
- Pediatric Use Safety and effectiveness in pediatric patients have not been established.
- KEEP THIS AND ALL DRUGS OUT OF REACH OF CHILDREN.
- Precautions: allergies
- Allergic sensitization has been reported following both oral and parenteral administration of folic acid.
- Storage
- STORAGE Store at controlled room temperature 15(0)-30(0)C (59(0)-86(0)F) [See USP]. Protect from light, moisture and excessive heat. Dispense in a tight, light resistant container as defined in the USP using a child-resistant closure.